Amoureux, M. C., Hegyi, E., Le, D., Grandics, P., Tong, H. and Szathmary, S. (2004): A new method for removing endotoxin from plasma using hemocompatible affinity chromatography technology, applicable for extracorporeal treatment of septic patients. J. Endotoxin Res. 10, 85-95.

Athamna, A., Kramer, M. R. and Kahane, I. (1996): Adherence of Mycoplasma pneumoniae to human alveolar macrophages. FEMS Immunol. Med. Microbiol. 15, 135-141.

Ben-Menachem, C., Zahringer, U. and Rottem, S. (2001): The phosphocholine motif in membranes of Mycoplasma fermentans strains. FEM Microbiol. Lett. 199, 137-141.

Brade, H., Opal, S. M., Vogel, S. M. and Morrison, D. C. (eds) (1999): Endotoxin in Health and Disease. Marcel Dekker, New York.

Christensen, N. D., Reed, C. A., Culp, T. D., Hermonat, P. L., Howett, M. K., Anderson, R. A. and Zaneveld, J. D. (2001): Papillomavirus microbicidal activities of high-molecular weight cellulose sulfate, dextrane-sulfate and polystyrene sulfonate. Antimicrob. Agent Chemother. 45, 3427-3432.

Elfaki, M. G., Kleven, S. H., Jin, L. H. and Ragland, W. L. (1993): Protection against airsacculitis with sequential systemic and local immunization of chickens using killed Mycoplasma gallisepticum bacteria with iota carrageenan adjuvant. Vaccine 11, 311-317.

Ernø, H. and Stipkovits, L. (1973): Bovine mycoplasmas: Culture and biochemical studies. Acta Vet. Scand. 14, 436-449.

Frey, J. (2002): Mycoplasmas of Animals. In: Rasin, S. and Herrmann, R. (eds) Molecular Biology and Pathogenicity of Mycoplasmas. Kluwer Academic/Plenum Publishers, New York. pp. 71-90.

Galanos, C., Gumenscheimer, M., Muhlradt, P., Jirillo, E. and Freudenberg, M. (2000): MALP-2, a Mycoplasma lipopeptide with classical endotoxic properties: end of an era of LPS monopoly? J. Endotoxin Res. 6, 471-476.

Giron, J. A., Lange, M. and Baseman, J. B. (1996): Adherence, fibronectin binding and induction of cytoskeleton reorganization in cultured human cells by M. penetrans. Infect. Immun. 64, 197-208.

Kenny, G. E. (1985): Mycoplasma contamination of cell cultures. In: Gylstorff, I. (ed.) Infektionen durch Mycoplasmatales. VEB Gustav Fischer Verlag, Jena. pp. 210-227.

Kleven, S. H. (1990): Summary of discussion of Avian Mycoplasma Team, IRPCM, IOM. Avian Pathol. 19, 795-800.

Krivan, H. C., Olson, L. D., Barile, M. F., Ginsburg, V. and Roberts, D. D. (1989): Adhesion of Mycoplasma pneumoniae to sulfated glycolipids and inhibition by dextran sulfate. J. Biol. Chem. 264, 9283-9288.

Markham, P. F., Glew, M. D., Brandon, M. R., Walker, J. D. and Whithear, K. G.(1992): Characterization of a major hemagglutinin protein from Mycoplasma gallisepticum. Infect. Immun. 60, 3885-3891.

Matsuda, K., Ishizuka, I. and Kasama, T. (1997): Structure of a novel phosphocholine-containing aminoglycoglycerolipid of Mycoplasma fermentans. Biochim. Biophys. Acta 1349, 1-12.

Muhlradt, P. F., Kiess, M., Meyer, H., Sussmuth, R. and Jung, G. (1997): Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J. Exp. Med. 185, 1951-1958.

Nishiguchi, M., Matsumoto, M. and Takao, T. (2001): Mycoplasma fermentans lipoprotein M161 Ag-induced cell activation is mediated by Toll-like receptor 2: Role of N-terminal hydrophobic portion in its multiple functions. J. Immunol. 164, 2610-2616.

Olson, L. D., Shane, S. W., Karpas, A. A., Cunningham, T. M., Probst, P. S. and Barile, M. F. (1991): Monoclonal antibodies to surface antigens of a pathogenic Mycoplasma hominis strain. Infect. Immun. 59, 1683-1689.

Olson, L. D. and Gilbert, A. A. (1993): Characteristics of Mycoplasma hominis adhesion. J. Bacteriol. 175, 3224-3227.

Pfützner, H. and Sachse, K. (1996): Mycoplasma bovis as an agent of mastitis, pneumonia, arthritis and genital disorders in cattle. Rev. Sci. Technol. 15, 1477-1494.

Rosengarten, R. and Wise, K. S. (1990): Phenotypic switching in Mycoplasmas: Phase variation of diverse surface lipoproteins. Science 247, 315-318.

Ross, R. F. (1990): Proc. Mycoplasma Pneumonia Symposia. SmithKline Beecham Animal Health, Ames, Iowa. p. 116.

Rottem, S. (1980): Membrane lipids of mycoplasmas. Biochim. Biophys. Acta 604, 65-90.

Rottem, S. and Barile, M. F. (1993): Beware of mycoplasmas. Tibtech 11, 143-151.

Smith, P. F., Langworthy, T. A. and Mayberry, W. R. (1976): Distribution and composition of lipopolysaccharides from mycoplasmas. J. Bacteriol. 125, 916-922.

Stipkovits, L., Molnár, T., Glávits, R., Szabó, I. and Thevasagayam, S. (2004): New opportunities in the control of Mycoplasma pneumonia in pigs [in Hungarian with English abstract]. Magyar Állatorvosok Lapja 126, 325-331.

Takeuchi, O., Kaufmann, A., Grote, K., Kawai, T., Hoshino, K., Morr, M., Muhlradt, P. F. and Akira, S. (2000): Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipo-lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a Toll-like receptor 2- and MyD88-dependent signaling pathway. J. Immunol. 164, 554-557.

Theiss, P. and Wise, K. S. (1997): Localized frameshift mutation generates selective, highfrequency phase variation of a surface lipoprotein encoded by a Mycoplasma ABC transporter operon. J. Bacteriol. 179, 4013-4022.

Washburn, L. R., Weaver, K. E., Weaver, E. J., Donelan, W. and Al-Sheboul, S. (1998): Molecular characterization of Mycoplasma arthritidis variable surface protein MAA2. Infect. Immun. 66, 2576-2586.

Zhang, Q., Young, T. F. and Ross, R. F. (1994): Glycolipid receptors for attachment of Mycoplasma hyopneumoniae to porcine respiratory ciliated cells. Infect. Immun. 62, 4367-4373.